Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lenexa, Kansas 66219


Purpose:

A total of 63 subjects will be recruited into three groups (18 subjects per group will receive MVA BN RSV vaccine and three subjects per group will receive placebo). Liquid frozen suspension of MVA BN RSV. Each subject will receive two vaccinations with either MVA-BN RSV vaccine 1 x 108 TCID50 per 0.5 ml, 1 x 107 TCID50 per 0.5 ml or with placebo.


Criteria:

Inclusion Criteria: - signed and dated an informed consent form - Body mass index ≥ 18.5 and < 35. - Women of childbearing potential (WOCBP) must have used an acceptable method of contraception Exclusion Criteria: - Pregnant or breast-feeding women. - Uncontrolled serious infection, i.e. not responding to antimicrobial therapy. - History of any serious medical condition. - History of or active autoimmune disease. - Known or suspected impairment of immunologic functions.


NCT ID:

NCT02419391


Primary Contact:

Principal Investigator
Casey Johnson, DO
Johnson County Clin-Trials (JCCT)


Backup Contact:

N/A


Location Contact:

Lenexa, Kansas 66219
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.